Upregulated expression has resulted in poorly differentiated prostate cancer (142,143), high expression of TGFB1 is also associated with mammary epithelial and breast carcinoma (144), pancreatic cancer (140), colorectal cancer (140), lung cancer (140) and metastatic melanoma (140). This evidence concerns the gene TGFB1 and lung carcinoma.